ELAB Overview

PMGC Holdings Inc. is a management, advisory, and investment company specializing in United States (U.S.)-based opportunities across financial services, manufacturing, and healthcare. Its segments include corporate, treasury and biosciences, IT packaging solutions and precision engineering and machining. The Company's portfolio consists of various subsidiaries: Northstrive BioSciences Inc., PMGC Research Inc., PMGC Capital LLC, Pacific Sun Packaging Inc. and AGA Precision Systems LLC. Northstrive Biosciences Inc. is a biopharmaceutical company focusing on the development and acquisition of aesthetic medicines. Its lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. PMGC Research Inc. is focused on advancing the frontiers of scientific discovery. AGA Precision Systems LLC specializes in CNC machining operations.

Wall Street analysts forecast ELAB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ELAB is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

PMGC Holdings Inc revenue for the last quarter amounts to 285.95K USD, decreased

PMGC Holdings Inc. EPS for the last quarter amounts to -19.64 USD, decreased -98.52

PMGC Holdings Inc (ELAB) has 2 emplpoyees as of March 02 2026.

Today ELAB has the market capitalization of 3.70M USD.